Target intelligence / Profile preview

Iron-containing complexes (Fe-complexes)

Target
Fe-complexes
Molecular classification
Metal ion complex, Inorganic compound, Other
01

Overview

Iron-containing complexes in tissue refer to the various physiological and pathological forms of iron storage and utilization, primarily including ferritin, hemosiderin, and the labile iron pool. Iron is an essential element for life, serving as a critical cofactor for hemoglobin, myoglobin, and numerous enzymes involved in electron transport and DNA synthesis. However, when iron levels exceed the capacity of storage proteins, free iron can catalyze the formation of reactive oxygen species via the Fenton reaction, leading to oxidative stress, lipid peroxidation, and organ damage. In clinical practice, these complexes are the primary target for iron chelation therapy in patients with chronic iron overload resulting from hereditary hemochromatosis or frequent blood transfusions. Drugs like deferoxamine and deferasirox mobilize iron from these tissue complexes to facilitate its excretion. Additionally, iron-containing complexes are significant in diagnostic imaging, where the paramagnetic properties of iron deposits are utilized in MRI to quantify iron loading in the liver and heart, guiding therapeutic interventions.

Other names
Tissue ironLabile iron poolIron storesFerritin-bound ironHemosiderinNon-heme iron
02

Mechanism of action

Iron chelators bind to ferric (Fe3+) or ferrous (Fe2+) ions within these complexes to form stable, non-toxic chelates that are excreted by the kidneys or liver, thereby reducing systemic and tissue-specific iron toxicity. Conversely, iron replacement therapies provide exogenous iron to replenish these complexes in cases of deficiency.

03

Biological functions

Oxygen transportElectron transportDNA synthesisRedox signalingCofactor for enzymatic reactions
04

Disease associations

Iron overload (Hemochromatosis)Transfusion-dependent thalassemiaSickle cell diseaseNeurodegenerative disease (e.g., Parkinson's, Alzheimer's)Sideroblastic anemiaChronic kidney disease
05

Safety considerations

Agranulocytosis (with Deferiprone)Renal toxicityHepatic impairmentGastrointestinal hemorrhageOcular and auditory toxicityInfection risk (e.g., Yersinia enterocolitica)
06

Interacting drugs

Deferoxamine

5 more in the full profile.

07

Biomarkers

Serum ferritinTransferrin saturation (TSAT)Liver iron concentration (LIC) via MRI R2*Myocardial iron (T2* MRI)Serum iron

Beyond the preview

Go deeper on Iron-containing complexes (Fe-complexes).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iron-containing complexes (Fe-complexes).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call